Nektar Therapeutics

(NKTR) Trade

By |

Profile

Nektar Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops a pipeline of drug candidates that utilizes its PEGylation and polymer conjugate technology platforms that are designed to develop molecular entities.

Contact Information

Website: www.nektar.com
Email: Investors@nektar.com
Main Phone: +1 415 482-5300
Address: 455 Mission Bay Boulevard South
State: CA
City / Town: San Francisco
Country: USA
Postal Code: 94158

Issuer Information

Exchange: NGS
Employees: 425
NAICS: Pharmaceutical P
$ 18.97 $ 0.04 (0.21%)
Last Price 18.97 Change $ 0.04 Change % 0.21 Tick N/A
Bid 15.15 Bid Size 100.00 Ask 22.80 Ask Size 100.00
Open 19.00 High 19.28 Low 18.74 Prev Close 18.93
Last Trade Volume 1.8 mi 52 Wk Hi 24.88 52 Wk Low 11.41
Market Cap 2.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 153,831,047.00 EPS (TTM) -1.10 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 115
Number of Buys 10 63
Number of Sells 10 52
Net Activity 164764 231759
Last 10 Buys Shares
Dennis L. Winger 1,000
Last 10 Sell Shares
Stephen K. Doberstein 1,000
John Nicholson 1,000
Jillian B. Thomsen 1,000
Gil M. Labrucherie 1,000
Ivan P. Gergel 1,000
Howard W. Robin 1,000
Maninder Hora 1,000
Robert B. Chess 1,000
Robert B. Chess 1,000
Robert B. Chess 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 21 20 20 25
Low Target Price Estimate 14 14 14 14
Mean Target Price Estimate 18.33 17.67 17.67 19.33
Standard Deviation 2.73 2.42 2.42 3.56
Date of Most Recent Estimate 08/12/16 08/04/16 07/27/16 08/22/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 7
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 1 1
Strong Sell 0 0 0 0
Mean Rec. 1 1 1.38 1.38